Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure (CROSBI ID 113580)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Kokić, Slaven ; Buković, Damir ; Radman, Maja ; Čapkun, Vesna ; Gabrić, Nikica ; Lesko, Vesna ; Karelović, Deni ; Stančerić, Tajana Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure // Collegium antropologicum, 27 (2003), 181-187

Podaci o odgovornosti

Kokić, Slaven ; Buković, Damir ; Radman, Maja ; Čapkun, Vesna ; Gabrić, Nikica ; Lesko, Vesna ; Karelović, Deni ; Stančerić, Tajana

engleski

Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure

The purpose of the study was to find out differences between treatments of diabetes type 2 after secondary oral antidiabetic drug failure. Three different methods of treatment were compared: lispro insulin in combination with metformin, glimepiride and metformin combination or two daily doses of biphasic insulin 30/70 together with bed -time NPH insulin. The study included 87 patients with diabetes mellitus type 2 randomly distributed into 3 different treatment groups. Fasting and postprandial glucose were analyzed by enzymatic colorimetric method and HbA(1c) was measured by ion exchange chromatography. HbA(1c) significantly decreased in all three study groups. The decrease was mostly expressed among patients treated with lispro and metformin. When focused on postprandial glucose control, antihyperglycemic metformin and insulin lispro therapy has greater impact on the overall metabolic control (decrease in level of HbA(1c) in comparison with the above mentioned more traditional approaches.

Lispro insulin ; Metformin ; Niddm ; Antidiabetic drug

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

27

2003.

181-187

objavljeno

0350-6134

1848-9486

Povezanost rada

nije evidentirano

Poveznice
Indeksiranost